about
The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the Fc epsilon RII/CD23 surface antigenThe role of apoptotic mimicry in host-parasite interplay: is death the only alternative for altruistic behavior?Indomethacin treatment slows disease progression and enhances a Th1 response in susceptible BALB/c mice infected with Leishmania majorLeishmania donovani: immunostimulatory cellular responses of membrane and soluble protein fractions of splenic amastigotes in cured patient and hamstersRecombinant soluble interleukin-4 (IL-4) receptor acts as an antagonist of IL-4 in murine cutaneous LeishmaniasisVaccines to combat the neglected tropical diseases.Leishmaniasis.Comparative analysis of the tissue inflammatory response in human cutaneous and disseminated leishmaniasis.Analysis of the immune responses of mice to infection with Leishmania braziliensisNucleosomal histone proteins of L. donovani: a combination of recombinant H2A, H2B, H3 and H4 proteins were highly immunogenic and offered optimum prophylactic efficacy against Leishmania challenge in hamsters.Parasitological and biochemical studies on cutaneous leishmaniasis in Shara'b District, Taiz, YemenSynthetic neoglycoconjugates of cell-surface phosphoglycans of Leishmania as potential anti-parasite carbohydrate vaccinesLow-dose UVB contributes to host resistance against Leishmania amazonensis infection in mice through induction of gamma interferon and tumor necrosis factor alpha cytokines.Occurrence of Leishmania infantum parasitemia in asymptomatic blood donors living in an area of endemicity in southern FranceActivation of skin dendritic cells by immunostimulatory DNA.Migration-inhibitory factor gene-deficient mice are susceptible to cutaneous Leishmania major infection.Immunization with a polyprotein vaccine consisting of the T-Cell antigens thiol-specific antioxidant, Leishmania major stress-inducible protein 1, and Leishmania elongation initiation factor protects against leishmaniasis.Th1 stimulatory proteins of Leishmania donovani: comparative cellular and protective responses of rTriose phosphate isomerase, rProtein disulfide isomerase and rElongation factor-2 in combination with rHSP70 against visceral leishmaniasis.The pathogenesis of Leishmania/HIV co-infection: cellular and immunological mechanisms.The immunology of parasite infections in immunocompromised hosts.Development of a leishmaniasis vaccine: the importance of MPL.Effects of sand fly vector saliva on development of cutaneous lesions and the immune response to Leishmania braziliensis in BALB/c mice.Characterization of immunoglobulin G and its subclass response to Indian kala-azar infection before and after chemotherapy.Progression of visceral leishmaniasis due to Leishmania infantum in BALB/c mice is markedly slowed by prior infection with Trichinella spiralis.Anti-human cytomegalovirus activity of cytokines produced by CD4+ T-cell clones specifically activated by IE1 peptides in vitro.Comparative immune study on cutaneous leishmaniasis patients with single and multiple soresAdjuvants for Leishmania vaccines: from models to clinical application.T cell and non-T cell compartments can independently determine resistance to Leishmania major.A recombinant Leishmania antigen that stimulates human peripheral blood mononuclear cells to express a Th1-type cytokine profile and to produce interleukin 12.Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice.Immunostimulatory oligodeoxynucleotides promote protective immunity and provide systemic therapy for leishmaniasis via IL-12- and IFN-gamma-dependent mechanismsThe central role of CD4(+) T cells in the antitumor immune response.Kinetoplastids: related protozoan pathogens, different diseases.A prime/boost DNA/Modified vaccinia virus Ankara vaccine expressing recombinant Leishmania DNA encoding TRYP is safe and immunogenic in outbred dogs, the reservoir of zoonotic visceral leishmaniasisCutaneous leishmaniasis: disease susceptibility and pharmacogenetic implications.Human immunodeficiency virus and leishmaniasis.Is leishmaniasis an "unusual suspect" of infection in allogeneic transplantation?F1 Domain of the Leishmania (Leishmania) donovani Nucleoside Hydrolase Promotes a Th1 Response in Leishmania (Leishmania) infantum Cured Patients and in Asymptomatic Individuals Living in an Endemic Area of Leishmaniasis.Cutaneous leishmaniasis: therapeutic strategies and future directions.Priming of a beta-galactosidase (beta-GAL)-specific type 1 response in BALB/c mice infected with beta-GAL-transfected Leishmania major.
P2860
Q24307697-D284C226-D932-4244-9A03-F578EC065AC8Q24800885-3B3959C7-4BE8-47CC-893E-07713B283228Q28375573-314E4302-C5A3-4D72-BB1A-1A901B7D7188Q28480398-D9E03A61-1D4F-4690-B3B7-F0323EF11628Q28505268-FAE930BC-BD6C-41A9-87D1-F24A70F4C0CCQ30425005-860C9232-7B78-4040-91F8-C984DDBBAAC9Q31107638-97BB4472-EC88-4117-B656-45C603EC7635Q33587057-4C3E8404-39D9-4A2C-8C50-19812790CD37Q33750694-EBFD4E57-2F48-4722-B27E-B51EAD12ADDFQ33753259-0B225B57-E96B-4FBB-BDAF-A93A2513BCD8Q33869978-E9C86A91-1261-429C-B39A-13406AA39FC9Q33870163-9B1EBF54-84AF-4C19-9E5A-D9EB6B5B22AAQ33943048-77C7BFBD-118A-4430-B030-B568C179EEACQ33961002-5B1B5977-69CB-4955-A5A5-520564B9ADEEQ34005392-8BD3B657-A6A5-4C2A-9BBC-730CF0DE0EA4Q34005968-9EA52B03-ACCA-41CD-9735-A59BEC9C4DB4Q34128082-4C540545-8902-4FEC-95BF-EA5153A1C203Q34277331-6AE4DB8D-B999-4E70-A577-E4FA419CDD6EQ34284119-D91A2F37-FE32-459A-B1AC-F86B7E36ED38Q35029729-F21329E8-F3BE-4DDE-AD7B-79DFA05A63C7Q35192190-DEE13E96-ABE8-4D4D-ABD8-81EE69B30F89Q35533110-95159F1D-4AE3-475E-8596-B3316D316CD5Q35548955-4A86800F-3722-4546-975E-353B05B0F319Q35559735-56939648-D4A0-4C36-8D72-D8D452084678Q35858429-006975C2-E512-4155-B546-B8589B73D231Q36010722-F133B46A-A170-44F1-A2F4-5DE9E671CE70Q36021357-6045FFE6-A266-45B7-B04B-882490F98A58Q36364627-43342B81-4944-46B0-BB33-901153A718F0Q36364671-360A1C31-C04D-484D-82C8-DEBA07794582Q36366305-2E379533-F2F0-4780-9E4A-5D00F32EB2E7Q36386875-3C45D736-8C3A-4ED6-BC8A-25E3B8E9FFE2Q36401381-23A4E747-D94C-4C93-85E4-C2FC95A0EC0AQ36513308-777468B5-5615-443E-ADD2-82CDCE75A773Q37144722-58DB670C-79C1-4D87-A874-7A3C8FFDA583Q37416125-B52B8B04-8743-4ADB-BDDA-514D51D15C4DQ37798456-7FF6E0D1-F3AF-495F-A221-E32E2C4C2187Q38269996-7494D562-FF7E-4DF5-82E5-4288A2F1172BQ38658902-6942361B-E603-484D-9C76-099BBFE6A2F5Q38872459-FC1615F8-1EDF-4590-BDF9-72622680ADB9Q38937093-8651D34F-5A65-4B85-9F4E-E57589204205
P2860
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
T-cell and cytokine responses in leishmaniasis.
@en
type
label
T-cell and cytokine responses in leishmaniasis.
@en
prefLabel
T-cell and cytokine responses in leishmaniasis.
@en
P1476
T-cell and cytokine responses in leishmaniasis.
@en
P304
P356
10.1016/0952-7915(93)90033-O
P577
1993-08-01T00:00:00Z